FDA Announces Recall Of Blood Lead Tests Due To “Significant Risk Of Falsely Low Results”

Cardiovascular Business (7/2, Walter) reported that “the FDA has announced that Magellan Diagnostics is recalling 13 lots of its LeadCare blood lead tests due to a ‘significant risk of falsely low results.’” The article added that “this is a Class I recal...